[Extension of the period of reversible ultrastructural changes in the myocardium during blood loss by using sodium oxybutyrate].
D000818:Animals; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D004734:Energy Metabolism / Q000187:drug effects; D005260:Female; D006470:Hemorrhage / Q000378:metabolism / Q000473:pathology*; D006885:Hydroxybutyrates / Q000008:administration & dosage; D007022:Hypotension / Q000378:metabolism / Q000473:pathology; D000860:Hypoxia / Q000378:metabolism / Q000473:pathology; D008297:Male; D008854:Microscopy, Electron; D009206:Myocardium / Q000378:metabolism / Q000648:ultrastructure*; D012978:Sodium Oxybate / Q000008:administration & dosage; D013997:Time Factors
D006885:Hydroxybutyrates; D012978:Sodium Oxybate
Udlinenie perioda obratimykh ul'trastrukturnykh izmeneniĭ miokarda pri krovopotere s pomoshch'iu oksibutirata natriia.